Metraipolis › archive › dc_6b239ebe8998

Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month… — Europe PMC PMID:42328256

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42328256
DOI
10.7759/cureus.111161
License (as archived)
solo-consultazione
Archived
2026-10-19T07:40:20.724Z
SHA-256 of the archived text
dbe1f733288698ab5fb638dffd12c5605f347457b11cf9b75f00738c445850e5
Stable URL of this page
https://metraipolis.com/documento/dc_6b239ebe8998

How to cite

Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month… — Europe PMC PMID:42328256 — Europe PMC (en), https://europepmc.org/article/MED/42328256 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b239ebe8998 (Metraipolis archive dc_6b239ebe8998, sha256 dbe1f733288698ab5fb638dffd12c5605f347457b11cf9b75f00738c445850e5)
BibTeX
@misc{dc6b239ebe8998,
  title = {Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month… — Europe PMC PMID:42328256},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42328256},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b239ebe8998; sha256 dbe1f733288698ab5fb638dffd12c5605f347457b11cf9b75f00738c445850e5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42328256. Agents can read the archived copy with the MCP tool read_document.